Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trialFan Yang, Jianxi Lu, Jintao Cheng et al.|Hepatology International|2023Cited by 31
Efficacy of cytokine-induced killer cell-based immunotherapy for hepatocellular carcinoma.Changchang Jia, Qi Zhang, Yunhao Chen et al.|PubMed|2019Cited by 17
Supplementary Data from Activation of YAP1 by N<sup>6</sup>-Methyladenosine–Modified circCPSF6 Drives Malignancy in Hepatocellular CarcinomaYunhao Chen, Shusen Zheng|Unknown|2023Cited by 0